Market Snapshot

BSE Sensex: 75867.8 -0.19%
BSE 500: 35899.16 0.31%
BSE 200: 11191.51 0.29%
BSE 100: 25430.71 0.13%
BSE BANKEX: 61796.59 -0.48%
BSE IT: 28045.94 -0.26%
Nifty 50: 23907.15 -0.03%
Nifty 500: 22967.4 0.31%
Nifty 200: 13861.6 0.28%
Nifty 100: 24970.85 0.24%
Nifty Midcap 100: 62558.85 0.42%
Nifty Small 100: 18294.3 0.15%
Nifty IT: 28906.7 -0.25%
Nifty PSU Bank: 8225.45 0.31%

News:

HDFC Bank ends lower amid repo...
Cummins India Q4 PAT jumps 25%...
Conart Engineers gains after b...
Bajaj Steel Inds slumps after ...
Zee Ent surges after unveiling...

Orchid Pharma Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

27 May 2026 | 04:14 PM

761.35

37.00 (5.11%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

8.12%

Return (1Y)

Beaten Nifty 50 by 11.82%
More Volatile

2.5%

Standard Deviation (1Y)

Higher than Nifty 50 by 1.69%
Not so consistent

5/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

899

480

News & Announcements

Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore
2 days ago

Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore

26 - May - 2026 12:00 | 2 days ago

Revenue from operations rose marginally to Rs 237.61 crore in Q4 FY26 as against Rs 237.48 crore posted in the same period last year.
Profit before exceptional items and tax stood at Rs 22.25 crore, up 16.55% from Rs 19.09 crore reported in Q4 FY25. The company reported exceptional items of Rs 0.54 crore during the quarter.
For the full financial year FY26, the company reported a 79.37% decline in consolidated net profit to Rs 20.55 crore, while revenue from operations fell 11.99% year-on-year to Rs 811.33 crore compared with FY25.
Orchid Pharma is a Chennai-based pharmaceutical company engaged in the development, manufacture and marketing of bulk actives, formulations and nutraceuticals, with exports to over 40 countries.
Powered by Capital Market - Live News

Orchid Pharma consolidated net profit rises 6.68% in the March 2026 quarter

2 days ago

Orchid Pharma to hold board meeting
8 days ago

Orchid Pharma to hold board meeting

20 - May - 2026 12:00 | 8 days ago

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 25 May 2026.
Orchid Pharma reports consolidated net loss of Rs 12.61 crore in the December 2025 quarter
105 days ago

Orchid Pharma reports consolidated net loss of Rs 12.61 crore in the December 2025 quarter

12 - Feb - 2026 12:00 | 105 days ago

Net loss of Orchid Pharma reported to Rs 12.61 crore in the quarter ended December 2025 as against net profit of Rs 20.78 crore during the previous quarter ended December 2024. Sales declined 4.63% to Rs 207.27 crore in the quarter ended December 2025 as against Rs 217.34 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 207.27 217.34 -5

OPM % 0.75 12.13 -

PBDT 3.99 31.06 -87

PBT -5.04 22.45 PL

NP -12.61 20.78 PL

Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

FII shareholding in Orchid Pharma Ltd has decreased by -25.65% since past 3 Months
MF shareholding in Orchid Pharma Ltd has increased by 7.88% since past 3 Months
FII shareholding in Orchid Pharma Ltd has decreased by -67.67% since past 1 Year
MF shareholding in Orchid Pharma Ltd has increased by 3.45% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60